Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
The suicide rate among patients with moderate to severe psoriasis was not significantly higher when compared with the general population. Suicide is a rare event and our results are limited by uncertainty about the reliability of the estimate. However, considering the high depression prevalence in psoriasis, our findings support the need for prompt assessment of patients for psychiatric comorbidities and suicidality history. Further research is required on suicidal behaviours and the role of psoriasis severity.
Authors
- Olivia Hughes (ORCID: https://orcid.org/0000-0001-9587-9430)
- Nick J. Reynolds (ORCID: https://orcid.org/0000-0002-6484-825X)
- Georgia Lada (ORCID: https://orcid.org/0000-0003-1926-2599)
- C. Elise Kleyn (ORCID: https://orcid.org/0000-0003-4038-5833)
- Shernaz Walton (ORCID: https://orcid.org/0009-0009-1018-1320)
- Ian M. Evans (ORCID: https://orcid.org/0000-0003-4336-8852)
- Anthony Bewley (ORCID: https://orcid.org/0000-0003-1195-0290)
- K.J. Mason (ORCID: https://orcid.org/0000-0002-5419-0669)
- Richard Bruce Warren (ORCID: https://orcid.org/0000-0002-2918-6481)
- K. Williams
- Kathleen McElhone
Institutions
- Greater Manchester Mental Health NHS Foundation Trust (GB)
- Queen Mary University of London (GB)
- University of Hull (GB)
- Barts Health NHS Trust (GB)
- Manchester Academic Health Science Centre (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Clinical Research Institute (US)
- Manchester University NHS Foundation Trust (GB)
- Arthritis UK (GB)
- NIHR Newcastle Biomedical Research Centre (GB)
- NIHR Manchester Biomedical Research Centre (GB)
- Keele University (GB)
- University of Newcastle Australia (AU)
- Cardiff University (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2024-10-19
- DOI
- https://doi.org/10.1093/ced/llae449
- Citations
- 2
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.48
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- National Institute for Health and Care Research
- British Association of Dermatologists
- LEO Pharma
- Samsung
- Manchester Biomedical Research Centre
- Cilag